Roger Becker

408 total citations
17 papers, 328 citations indexed

About

Roger Becker is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Roger Becker has authored 17 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Roger Becker's work include Pharmacogenetics and Drug Metabolism (4 papers), Liver physiology and pathology (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Roger Becker is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Liver physiology and pathology (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Roger Becker collaborates with scholars based in Germany, Brazil and France. Roger Becker's co-authors include Franz Oesch, Rolf Meinert, Jan G. Hengstler, Berno Tanner, P. G. Knapstein, Thomas Friedberg, Michael Arand, Franz Oesch, Nadja Dornhöfer and Hansruedi Glatt and has published in prestigious journals such as Hepatology, Biochemical Journal and International Journal of Cancer.

In The Last Decade

Roger Becker

17 papers receiving 320 citations

Peers

Countries citing papers authored by Roger Becker

Since Specialization

Citations

This map shows the geographic impact of Roger Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Becker more than expected).

Fields of papers citing papers by Roger Becker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Becker. The network helps show where Roger Becker may publish in the future.

Co-authorship network of co-authors of Roger Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Becker. A scholar is included among the top collaborators of Roger Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Becker. Roger Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	PCN87 REAL-WORLD COSTS OF BLADDER CANCER TREATMENT IN LEBANON USING A PRIVATE PAYER DATASET 2019 ·Value in Health ·(unknown), (unknown), (unknown), (unknown), Roger Becker	3
2	cAMP-dependent phosphorylation of CYP2B1 as a functional switch for cyclophosphamide activation and its hormonal controlin vitro andin vivo 2001 ·International Journal of Cancer ·Barbara Oesch‐Bartlomowicz, Bernd Richter, Roger Becker, (unknown), P. R. Padma, Jan G. Hengstler, Franz Oesch	26
3	Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer 1999 ·PubMed ·Jan G. Hengstler, (unknown), (unknown), Nadja Dornhöfer, Rolf Meinert, Michael Arand, P. G. Knapstein, Roger Becker, Franz Oesch, Berno Tanner	87
4	The Human P53 Gene Mutated At Position 249 Per Se Is Not Sufficient to Immortalize Human Liver Cells 1999 ·Hepatology ·(unknown), Roger Becker, Franz Oesch, Pablo Steinberg	4
5	The cost effectiveness of tamoxifen in the prevention of breast cancer. 1999 ·PubMed ·(unknown), Roger Becker, WJ Gradishar, (unknown), (unknown)	19
6	C-myc mRNA Expression in Epithelial Ovarian Carcinomas in Relation to Estrogen Receptor Status, Metastatic Spread, Survival Time, FIGO Stage, and Histologie Grade and Type 1998 ·International Journal of Gynecological Pathology ·B. Tanner, Jan G. Hengstler, Andreas Luch, Rolf Meinert, (unknown), Michael Arand, (unknown), (unknown), Franz Oesch, P. G. Knapstein, Roger Becker	18
7	mdm2 mRNA expression is associated with survival in ovarian cancer 1997 ·International Journal of Cancer ·Berno Tanner, Jan G. Hengstler, (unknown), Rolf Meinert, Franz Oesch, (unknown), P. G. Knapstein, Roger Becker	30
8	The role of insulin-like growth factor II in the malignant transformation of rat liver oval cells 1997 ·Hepatology ·(unknown), (unknown), Margarete Odenthal, Roger Becker, Franz Oesch, H. P. Dienes, Peter Schirmacher, Pablo Steinberg	12
9	Prognostic Significance of c-erbB-2 mRNA in Ovarian Carcinoma 1996 ·Gynecologic Oncology ·Berno Tanner, (unknown), (unknown), Rolf Meinert, Franz Oesch, P. G. Knapstein, Roger Becker	40
10	Investigating the Role of the Microsomal Epoxide Hydrolase Membrane Topology and Its Implication for Drug Metabolism Pathways 1996 ·Advances in experimental medicine and biology ·Thomas Friedberg, (unknown), Roger Becker, (unknown), Michael Arand, Franz Oesch	1
11	Ha-ras^Va112 but not p53^Ser247 leads to a significant neoplastic transformation rate of the putative rat liver stem cells (oval cell) 1996 ·Carcinogenesis ·Roger Becker, (unknown), Franz Oesch, Hans‐Peter Dienes, (unknown)	7
12	Malignantly transformed non-parenchymal liver epithelial cells and transformed oval cells suppress the homotypical gap junctional intercellular communication of co-cultured rat liver parenchymal cells 1995 ·Carcinogenesis ·Bernd Diener, Roger Becker, Hans‐Jörg Martus, (unknown), Pablo Steinberg, Franz Oesch	3
13	Studies on the importance of microsomal epoxide hydrolase in the detoxification of arene oxides using the heterologous expression of the enzyme in mammalian cells 1994 ·Carcinogenesis ·Thomas Friedberg, Roger Becker, Franz Oesch, Hansruedi Glatt	20
14	The microsomal epoxide hydrolase has a single membrane signal anchor sequence which is dispensable for the catalytic activity of this protein 1994 ·Biochemical Journal ·Thomas Friedberg, (unknown), Roger Becker, (unknown), Franz Oesch	27
15	Differential changes of nuclear-envelope-associated enzyme activities involved in nucleocytoplasmic mRNA transport in the developing rat brain and liver 1986 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Heinz C. Schröder, Roger Becker, Michael Bachmann, Monika Gramzow, Annie‐Pierre Sève, Michel Monsigny, Wernér E.G. Müller	16
16	The heterogeneity of LDH isoenzyme patterns of human uterine sarcomas and cultured sarcoma cell lines. 1984 ·PubMed ·Karen G. Nelson, Jill M. Siegfried, Gene P. Siegal, Roger Becker, Leslie A. Walton, David G. Kaufman	12
17	[On the therapy of ameloblastoma]. 1967 ·PubMed ·Roger Becker, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact